Controlled substance lifecycle

What happens to a controlled substance from order to destruction: which DEA form does which job, receiving and storage rules, PDMPs, take-back and loss reporting.

DEA Forms — Quick Reference

Mnemonic: "41 = Forty-One Final" (destruction), "106 = Lost-and-Stolen Sixes" (theft/loss; S-I-X → Stolen), "222 = 2 of every 2" (order CII; single-sheet replaced triplicate), "224 = Door" (new pharmacy registration). Pair with "2-2-2 DEA records" (Form 222 + 2-year retention + 2 witnesses for take-back). See the Mnemonic Library cheat sheet Section 1.

Definition: CSOS is the DEA electronic ordering platform that lets authorized registrants transmit controlled-substance orders without paper Form 222.

Definition: DEA Form 222 is the official paper order document used by authorized registrants for Schedule I and II controlled substances.

Ordering Controlled Substances

DEA Form 222 (Schedule I and II — Paper)

• DEA Form 222 is the paper order form eligible registrants use for Schedule I or II controlled substances.
• Form 222 must be completed and signed by the pharmacy's "authorized person" — an individual the registrant has granted power of attorney specifically to sign Form 222 on behalf of the pharmacy. Not every employee can sign.
• Form 222 must be completed when the shipment is received and is filed separately along with the related invoice and packing slip.
• Each Form 222 is limited in the number of line items it can hold. The current single-sheet Form 222 (introduced October 30, 2019; triplicate retired October 30, 2021) allows up to 20 line items per form; the legacy triplicate form allowed 10. This per-form line-item cap is a key operational distinction from CSOS.

CSOS (Electronic Ordering — Schedules I-V)

• CSOS (Controlled Substance Ordering System) is the DEA's secure electronic ordering pathway for controlled substances.
• Authorized purchasers must enroll with the DEA to acquire a digital CSOS certificate. The digital certificate is the electronic credential that replaces the paper Form 222 signature.
• When used appropriately, CSOS supports ordering across Schedules I-V — the full controlled-substance range, not just CII.

CSOS Advantages over Paper Form 222

• No line-item limit — CSOS orders can include as many line items as needed, enabling just-in-time ordering across Schedules I-V.
• Faster transactions support just-in-time ordering and inventory management.
• Less manual paperwork and fewer ordering errors.
• Lower transaction costs through reduced rework.
• Tighter inventory management and cleaner documentation.

Diversion Prevention in Ordering

• Some pharmacies separate ordering from receiving so the same person is not doing both steps.
• That division of duties is a procurement control intended to reduce diversion risk.

CII Ordering Timeline

• Schedule II procurement usually involves more steps than routine legend-drug ordering, so turnaround can be slower.
• CSOS electronic ordering may shorten the process depending on the wholesaler and workflow.

Technician Role

• Technicians often support controlled-substance workflow, but the work happens inside tighter legal and policy boundaries.
• Two recurring exam themes: CII ordering requires extra documentation or approved electronic methods, and perpetual inventory is common for CII in practice even though the federal baseline centers on accurate records plus initial and biennial inventories.

Receiving Controlled Substances

• Controlled substances carry more receipt documentation than routine legend drugs.
• For Schedule II products ordered on paper, DEA Form 222 must be completed when the shipment is received.
• The completed Form 222 is typically filed separately along with the related invoice and packing slip.
• Receiving staff compare what arrived against what was ordered and document any discrepancy promptly.

Common Trap: If a noncontrolled substance is missing from a shipment (for example, sildenafil), the pharmacy notifies the wholesaler or distributor — not the DEA. The DEA is contacted only for controlled-substance theft or significant loss. Technicians sometimes default to "DEA" for any shipment problem; that is not the right escalation for ordinary missing stock.

Mnemonic: "Wholesaler, Not DEA" for missing noncontrolled shipments. Pair with "Biennial = Bi-yearly" (every 2 years) for CS inventory cycle. See the Mnemonic Library cheat sheet Sections 1 and 11.

Storing Controlled Substances

Schedule II — Tight Accountability

• Many pharmacies maintain a perpetual inventory of Schedule II products as a matter of state law, accreditation standard, or employer policy.
• Federal law requires complete and accurate controlled-substance records, including an initial inventory and biennial inventories (every 2 years).
• CII products should be stored and tracked with tight accountability to reduce diversion and support accurate recordkeeping.

Schedule III, IV, and V — Variable Requirements

• CIII-V items are often purchased through the standard wholesaler process used for other prescription inventory.
• Storage and receiving rules may still become stricter because of state law or site-specific policy.
• Examples include separate filing of receipts, readily retrievable paperwork, or different shelving approaches for controlled stock.

Diversion Prevention Programs

Modern pharmacies and health systems run a formal controlled-substance diversion-prevention program with two layers:

• Administrative: legal, regulatory, management oversight, and accountability measures.
• System controls: automated safeguards, diversion-detection tools, ongoing monitoring, investigation workflows, and required reporting.

Written site policies should define how controlled substances are received, secured, tracked, investigated, and reported.

Exam Tip: Controlled substances carry legal requirements across the entire workflow — ordering, storage, inventory, dispensing, returns, waste, and disposal. The lifecycle is continuous; no step is optional.

State Prescription Drug Monitoring Programs (PDMPs)

Many states operate prescription drug monitoring programs (PDMPs) under state law to track controlled-substance prescribing and dispensing activity.

Schedules Covered:

• Most state programs require reporting for Schedules II, III, IV, and V.
• Some programs cover only Schedules II, III, and IV.

Reporting Frequency:

• Pharmacies submit controlled-substance prescription data to the state authority electronically on a schedule set by state law, which may be daily, near-real-time, or another periodic interval.

Information Reported:

Uses of PDMPs:

• Flag refill patterns or prescribing histories that suggest possible diversion or misuse.
• Support earlier identification of patients who may need additional evaluation or substance-use treatment.
• Give pharmacists and prescribers another review point before writing or filling a controlled-medication order.

Pharmacies report controlled-substance dispensing data to PDMP systems so states can spot possible diversion, misuse, or duplicate therapy patterns earlier.

Exam Tip: PDMPs track only controlled substances. For a noncontrolled prescription, the technician would NOT query the PDMP. The correct first step for a noncontrolled Rx is verifying that all required information is legibly included.

Labeling and Dispensing

(For prescription validity, refill, transfer, and schedule rules, see Study Guide 2.2: Controlled Substances. This chapter focuses on what happens after a valid CS order reaches the pharmacy.)

Labeling Requirements

• The "C" symbol (circled C with the schedule number — CII, CIII, CIV, CV) must appear on manufacturer packaging of controlled substances.
• Federal transfer warning label (required verbatim text):

"Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed."

• This exact statement must appear on the patient's prescription container for every dispensed Schedule II, III, or IV controlled substance (21 CFR 290.5 — Schedule V is outside the federal mandate, though state law may add it). Memorize the wording — the PTCE tests it verbatim. (See Study Guide 2.2 for the corresponding responsibility doctrine and prescription validity rules.)

Recordkeeping

• Pharmacies must keep complete, accurate records for controlled drugs that are bought, received, transferred, dispensed, wasted, or otherwise handled.
• Federal retention is 2 years minimum, with records in a form the DEA can inspect readily.
• State law may extend retention beyond the federal minimum.

Types of Records:

• Each inventory captures a full and accurate count of the controlled substances present on the date the inventory is taken.
• Multi-site operations keep inventory records by location, not as a pooled total.

Biennial Inventory

• A DEA-registered pharmacy performs an opening inventory when operations begin or ownership changes.
• After that, the site completes a new controlled-substance inventory at least every 2 years.
• On each inventory, Schedule II counts must be exact. Schedule III-V counts may be estimated, unless an opened container holds more than 1,000 dosage units — then that container is counted exactly.

Common Trap: "Biennial" means every 2 years. Do not confuse it with "biannual" (twice per year). OSHA bloodborne pathogen training is annual (every year), while CS inventory is biennial (every 2 years). This is the classic PTCE swap distractor.

Returning Pharmaceuticals

General return-to-stock, credit-return, reverse-distributor, PDMA, and investigational-return workflows are covered in Study Guide 4.4: Returns and Disposal. Controlled substances are different — they follow DEA-governed pathways for take-back, loss or theft, and destruction instead of the standard return processes.

Take-Back Programs

DEA-Authorized Collection Receptacles

• The DEA authorizes pharmacies and other locations to maintain collection receptacles for patients to dispose of unwanted or expired controlled substances safely.
• These collection receptacles must have a sealed inner liner.

Inner Liner Change Procedure

• When the inner liner needs to be removed or replaced, at least two authorized employees must be present to witness the process and ensure proper chain of custody.
• The sealed inner liner is then shipped to a reverse distributor for destruction.

National Prescription Drug Take Back Day

• DEA-sponsored events held twice per year.
• The public can bring unused medications to designated collection sites for safe disposal.
• Purpose: reduce diversion and accidental poisoning by removing unused controlled substances from homes.

Exam Tip: In a pharmacy take-back receptacle workflow, inner-liner changes require two authorized employees and the sealed liner is transferred according to DEA collector rules.

Destruction and Disposal (DEA Form 41)

• Expired controlled drugs follow a separate destruction path from ordinary return-for-credit workflow.
• They are generally not sent back like routine stock returns.
• Disposal must follow applicable state and federal rules, and the pharmacy maintains the required destruction documentation.

DEA Form 41

• Registrant Record of Controlled Substances Destroyed (DEA Form 41) is the specific form for recording the disposal of expired controlled substances. (Older materials title it "Registrant's Inventory of Drugs Surrendered.")

Who Performs the Disposal

Ideally, disposal is completed by:

• A company sanctioned by the DEA, or
• A state board of pharmacy designee.

The DEA may allow destruction by a pharmacy provided the appropriate witness process is followed and documented.

Documentation

• DEA Form 41 is completed properly as the record of destruction and maintained according to DEA and state requirements.
• A copy is not routinely submitted to the DEA unless specifically requested.

Exam Tip: Disposal rules for controlled substances come from the DEA, not the FDA, manufacturer, or wholesaler. DEA authority covers how damaged, expired, returned, recalled, unused, or otherwise unwanted controlled drugs are collected, transferred, and destroyed.

Loss or Theft (DEA Form 106)

• If a theft or significant loss of controlled substances occurs, the DEA must be notified promptly.
• The official loss/theft document is DEA Form 106 — Report of Theft or Loss of Controlled Substances.
• The federal rule: Pharmacies are required to immediately report any theft or significant loss of controlled substances to the DEA using DEA Form 106.
• Current DEA rule (21 CFR 1301.74(c) and 1301.76(b), as amended June 2023): The registrant must take two steps. First, preliminarily notify the DEA field office in writing within one business day of discovery (email or fax; phone alone does not satisfy). Second, file a completed Form 106 electronically through the DEA Diversion Control secure network application within 45 calendar days of discovery. Paper Form 106 has not been accepted since July 24, 2023.
• On the PTCE, "immediately" and "within one business day" both capture the preliminary-notice rule; 45 calendar days is the electronic-submission deadline.
• A copy of Form 106 is typically sent to the state board of pharmacy per state requirements.

Pharmacist Call Required: Discovery of theft or significant loss is a pharmacist-notification event before any Form 106 submission. The PIC reviews the discrepancy, decides if the loss meets the "significant" threshold, and coordinates with the DEA field office and state board.

Common Traps

Here's where people miss it on Section 2.3. The chapter scatters these warnings inline as you read; this section pulls them together so they are easy to drill before the exam.

• Defaulting to "DEA" for any shipment problem. If a noncontrolled substance is missing from a shipment (for example, sildenafil), the pharmacy notifies the wholesaler or distributor — not the DEA. The DEA is contacted only for controlled-substance theft or significant loss via Form 106. Ordinary missing stock is a wholesaler issue.
• Confusing "biennial" with "biannual." Federal controlled-substance inventory is biennial — every 2 years. Biannual means twice per year. OSHA bloodborne-pathogens training is annual (every year). The exam writes the biennial/biannual swap as a classic distractor.
• Teaching the legacy 10-line cap as current. The current single-sheet DEA Form 222 (introduced October 30, 2019; triplicate retired October 30, 2021) allows up to 20 line items. The legacy triplicate form allowed 10 — that is history. CSOS has no line-item limit.
• Assuming Form 41 is routinely sent to the DEA. DEA Form 41 is the destruction record the pharmacy completes and retains. A copy is not routinely submitted to the DEA — only when the DEA specifically requests it. Form 106, by contrast, is filed with the DEA.
• Querying the PDMP for a noncontrolled prescription. PDMPs track controlled substances only. For a noncontrolled Rx, the correct first step is verifying that all required information is legibly present — not a PDMP query.
• Pooling multi-site inventory. Multi-location operations keep controlled-substance inventory records by location, not as a single combined total.
• Skipping the pharmacist on a loss discovery. Discovery of a theft or significant loss is a pharmacist-notification event before any Form 106 submission. The PIC reviews the discrepancy, decides whether the loss meets the "significant" threshold, and coordinates with the DEA field office and state board.
• Treating perpetual inventory as the federal requirement. Perpetual inventory of CII is common in practice (state law, accreditation, or employer policy), but it does not replace the federal requirement for an opening inventory and biennial counts.
• Sending recalled or expired controlled substances through ordinary return-for-credit. Expired and recalled controlled substances follow DEA-governed destruction pathways (Form 41 recordkeeping, reverse distributor) — not the routine return-for-credit routing used for noncontrolled stock.
• Misreading the "immediately" rule for CS loss. Under the current DEA rule, the registrant must preliminarily notify the DEA field office in writing within one business day of discovery and file the completed Form 106 electronically within 45 calendar days. "Immediately" and "within one business day" both capture the preliminary notice; 45 calendar days is the electronic-submission deadline.

Quick Review Checklist

A fast scan of the highest-yield Section 2.3 facts. If any line does not land, go back to the matching body section before moving on.

• DEA Form 222 — paper order form for Schedule I and II. Current single-sheet form allows up to 20 line items; legacy triplicate allowed 10.
• CSOS — DEA's electronic ordering system; covers Schedules I-V; no line-item limit; requires DEA enrollment and a digital certificate (not shareable between employees).
• DEA Form 106 — Report of Theft or Loss; written notice to the DEA field office within one business day of discovery, electronic Form 106 within 45 calendar days.
• DEA Form 41 — Registrant Record of Controlled Substances Destroyed (destruction record); retained, not routinely submitted to the DEA.
• Who signs Form 222 — the registrant's authorized person (an individual with specific power of attorney). A technician generally may not sign Form 222 or Form 41.
• Inventory — an opening (initial) inventory at start of operations or change of ownership, then a biennial count every 2 years.
• Record retention — federal minimum 2 years, readily retrievable for DEA inspection; CII records filed separately from CIII/IV/V; inventory kept by location.
• Federal transfer warning (verbatim) — "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed." Required on every dispensed Schedule II, III, or IV container (21 CFR 290.5; not Schedule V).
• Take-back receptacles — must have a sealed inner liner; inner-liner removal/replacement requires at least two authorized employees; the sealed liner goes to a reverse distributor for destruction.
• National Prescription Drug Take Back Day — DEA-sponsored, twice per year.
• PDMP — state-run; tracks controlled substances only (most cover CII-V, some CII-IV); reporting is electronic on a state-set schedule.
• Missing noncontrolled stock — notify the wholesaler/distributor; the DEA is for controlled-substance theft or significant loss only.
• CS disposal authority — the DEA governs collection, transfer, and destruction of unwanted controlled substances, not the FDA, manufacturer, or wholesaler.

Related

DEA schedules, refills and transfers · What is on the PTCE and how it is weighted · All Federal Requirements guides